• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

SORL1 基因变异与阿尔茨海默病的脑脊液生物标志物。

SORL1 genetic variants and cerebrospinal fluid biomarkers of Alzheimer’s disease.

出版信息

Eur Arch Psychiatry Clin Neurosci. 2012 Sep;262(6):529-34. doi: 10.1007/s00406-012-0295-x.

DOI:10.1007/s00406-012-0295-x
PMID:22286501
Abstract

The neuronal sortilin-related receptor with A-type repeats (SORL1, also called LR11 or sorLA) is involved in amyloidogenesis, and the SORL1 gene is a major risk factor for Alzheimer’s disease (AD). We investigated AD-related CSF biomarkers for associations with SORL1 genetic variants in 105 German patients with mild cognitive impairment (MCI) and AD. The homozygous CC-allele of single nucleotide polymorphism (SNP) 4 was associated with increased Tau concentrations in AD, and the minor alleles of SNP8, SNP9, and SNP10 and the haplotype CGT of these SNPs were associated with increased SORL1 concentrations in MCI. SNP22 and SNP23, and the haplotypes TCT of SNP19-21-23, and TTC of SNP22-23-24 were correlated with decreased Ab42 levels in AD. These results strengthen the functional role of SORL1 in AD.

摘要

神经元 SORL1 相关受体 A 型重复(SORL1,也称为 LR11 或 sorLA)参与淀粉样蛋白形成,SORL1 基因是阿尔茨海默病(AD)的主要危险因素。我们研究了与 SORL1 基因变异相关的 AD 相关 CSF 生物标志物,这些变异与 105 名德国轻度认知障碍(MCI)和 AD 患者有关。单核苷酸多态性(SNP)4 的纯合 CC 等位基因与 AD 中 Tau 浓度的增加有关,SNP8、SNP9 和 SNP10 的次要等位基因以及这些 SNP 的 CGT 单倍型与 MCI 中 SORL1 浓度的增加有关。SNP22 和 SNP23 以及 SNP19-21-23 的 TCT 单倍型和 SNP22-23-24 的 TTC 单倍型与 AD 中 Ab42 水平的降低有关。这些结果加强了 SORL1 在 AD 中的功能作用。

相似文献

1
SORL1 genetic variants and cerebrospinal fluid biomarkers of Alzheimer’s disease.SORL1 基因变异与阿尔茨海默病的脑脊液生物标志物。
Eur Arch Psychiatry Clin Neurosci. 2012 Sep;262(6):529-34. doi: 10.1007/s00406-012-0295-x.
2
Impact of SORL1 single nucleotide polymorphisms on Alzheimer's disease cerebrospinal fluid markers.SORL1 单核苷酸多态性对阿尔茨海默病脑脊液标志物的影响。
Dement Geriatr Cogn Disord. 2011;32(3):164-70. doi: 10.1159/000332017. Epub 2011 Oct 13.
3
Interrelations between CSF soluble AβPPβ, amyloid-β 1-42, SORL1, and tau levels in Alzheimer's disease.阿尔茨海默病患者脑脊液可溶性 AβPPβ、淀粉样蛋白-β1-42、SORL1 和 tau 水平之间的相互关系。
J Alzheimers Dis. 2012;28(3):543-52. doi: 10.3233/JAD-2011-110983.
4
Influence of genetic variants in SORL1 gene on the manifestation of Alzheimer's disease.SORL1基因中的遗传变异对阿尔茨海默病表现的影响。
Neurobiol Aging. 2015 Mar;36(3):1605.e13-20. doi: 10.1016/j.neurobiolaging.2014.12.007. Epub 2014 Dec 11.
5
SORL1 gene, plasma biomarkers, and the risk of Alzheimer's disease for the Han Chinese population in Taiwan.SORL1基因、血浆生物标志物与台湾汉族人群患阿尔茨海默病的风险
Alzheimers Res Ther. 2016 Dec 30;8(1):53. doi: 10.1186/s13195-016-0222-x.
6
Influence of SORL1 gene variants: association with CSF amyloid-beta products in probable Alzheimer's disease.SORL1基因变异的影响:与可能的阿尔茨海默病中脑脊液淀粉样β产物的关联
Neurosci Lett. 2008 Jul 25;440(1):68-71. doi: 10.1016/j.neulet.2008.05.049. Epub 2008 May 18.
7
SORL1 genetic variants modulate risk of amnestic mild cognitive impairment in northern Han Chinese.SORL1 基因变异可调节北方汉族人群遗忘型轻度认知障碍的发病风险。
Int J Neurosci. 2014 Apr;124(4):296-301. doi: 10.3109/00207454.2013.850429. Epub 2013 Nov 7.
8
Amyloid cascade and tau pathology cerebrospinal fluid markers in mild cognitive impairment with regards to Alzheimer's disease cerebral metabolic signature.淀粉样蛋白级联和 tau 病理学脑脊液标志物在轻度认知障碍阿尔茨海默病大脑代谢特征方面。
J Alzheimers Dis. 2013;36(2):401-8. doi: 10.3233/JAD-122329.
9
The SORL1 polymorphism rs985421 may confer the risk for amnestic mild cognitive impairment and Alzheimer's disease in the Han Chinese population.SORL1基因多态性rs985421可能会增加汉族人群患遗忘型轻度认知障碍和阿尔茨海默病的风险。
Neurosci Lett. 2014 Mar 20;563:80-4. doi: 10.1016/j.neulet.2014.01.029. Epub 2014 Jan 29.
10
Association of SORL1 gene variants with Alzheimer's disease.SORL1基因变异与阿尔茨海默病的关联。
Brain Res. 2009 Apr 6;1264:1-6. doi: 10.1016/j.brainres.2009.01.044. Epub 2009 Feb 3.

引用本文的文献

1
Soluble SorLA in CSF, a novel biomarker to explore disrupted trafficking of SorLA protein in Alzheimer disease.脑脊液中的可溶性SorLA,一种用于探索阿尔茨海默病中SorLA蛋白转运受损的新型生物标志物。
Alzheimers Res Ther. 2025 May 7;17(1):100. doi: 10.1186/s13195-025-01748-0.
2
Hypometabolism, Alzheimer's Disease, and Possible Therapeutic Targets: An Overview.代谢低下、阿尔茨海默病与可能的治疗靶点:概述。
Cells. 2023 Aug 8;12(16):2019. doi: 10.3390/cells12162019.
3
Association of multiple candidate genes with mild cognitive impairment in an elderly Chinese Uygur population in Xinjiang.

本文引用的文献

1
Perfusion abnormalities in mild cognitive impairment and mild dementia in Alzheimer's disease measured by pulsed arterial spin labeling MRI.用脉冲动脉自旋标记 MRI 测量阿尔茨海默病轻度认知障碍和轻度痴呆的灌注异常。
Eur Arch Psychiatry Clin Neurosci. 2012 Feb;262(1):69-77. doi: 10.1007/s00406-011-0226-2. Epub 2011 Jul 24.
2
CSF soluble amyloid precursor proteins in the diagnosis of incipient Alzheimer disease.脑脊液可溶性淀粉样前体蛋白在早期阿尔茨海默病诊断中的应用。
Neurology. 2011 Jul 5;77(1):35-8. doi: 10.1212/WNL.0b013e318221ad47. Epub 2011 Jun 22.
3
Meta-analysis of the association between variants in SORL1 and Alzheimer disease.
多个候选基因与新疆老年维吾尔族人群轻度认知障碍的关联。
Psychogeriatrics. 2019 Nov;19(6):574-583. doi: 10.1111/psyg.12440. Epub 2019 Apr 14.
4
Informatics Support for Basic Research in Biomedicine.生物医学基础研究的信息学支持
ILAR J. 2017 Jul 1;58(1):80-89. doi: 10.1093/ilar/ilx004.
5
SORL1 gene, plasma biomarkers, and the risk of Alzheimer's disease for the Han Chinese population in Taiwan.SORL1基因、血浆生物标志物与台湾汉族人群患阿尔茨海默病的风险
Alzheimers Res Ther. 2016 Dec 30;8(1):53. doi: 10.1186/s13195-016-0222-x.
6
Risk factor SORL1: from genetic association to functional validation in Alzheimer's disease.风险因素SORL1:从阿尔茨海默病的基因关联到功能验证
Acta Neuropathol. 2016 Nov;132(5):653-665. doi: 10.1007/s00401-016-1615-4. Epub 2016 Sep 16.
7
Effect of Alzheimer's Disease Risk Variant rs3824968 at SORL1 on Regional Gray Matter Volume and Age-Related Interaction in Adult Lifespan.阿尔茨海默病风险变异体rs3824968在SORL1基因上对成人寿命期区域灰质体积及年龄相关相互作用的影响
Sci Rep. 2016 Mar 21;6:23362. doi: 10.1038/srep23362.
8
Y682G Mutation of Amyloid Precursor Protein Promotes Endo-Lysosomal Dysfunction by Disrupting APP-SorLA Interaction.淀粉样前体蛋白的Y682G突变通过破坏APP-SorLA相互作用促进内溶酶体功能障碍。
Front Cell Neurosci. 2015 Apr 7;9:109. doi: 10.3389/fncel.2015.00109. eCollection 2015.
9
The role of the retromer complex in aging-related neurodegeneration: a molecular and genomic review.逆转录复合物在衰老相关神经退行性变中的作用:分子与基因组综述
Mol Genet Genomics. 2015 Apr;290(2):413-27. doi: 10.1007/s00438-014-0939-9. Epub 2014 Oct 21.
10
The Role of SORL1 in Alzheimer's Disease.SORL1在阿尔茨海默病中的作用。
Mol Neurobiol. 2015;51(3):909-18. doi: 10.1007/s12035-014-8742-5. Epub 2014 May 16.
SORL1基因变异与阿尔茨海默病关联的荟萃分析。
Arch Neurol. 2011 Jan;68(1):99-106. doi: 10.1001/archneurol.2010.346.
4
High cerebrospinal tau levels are associated with the rs242557 tau gene variant and low cerebrospinal β-amyloid in Parkinson disease.帕金森病患者脑脊液中高tau 水平与 rs242557 tau 基因变异和低β-淀粉样蛋白有关。
Neurosci Lett. 2011 Jan 7;487(2):169-73. doi: 10.1016/j.neulet.2010.10.015. Epub 2010 Oct 15.
5
Increased levels of soluble LR11 in cerebrospinal fluid of patients with Alzheimer disease.阿尔茨海默病患者脑脊液中可溶性 LR11 水平升高。
Dement Geriatr Cogn Disord. 2010;30(1):28-32. doi: 10.1159/000315539. Epub 2010 Jul 30.
6
Validating predicted biological effects of Alzheimer's disease associated SNPs using CSF biomarker levels.利用脑脊液生物标志物水平验证阿尔茨海默病相关 SNP 的预测生物学效应。
J Alzheimers Dis. 2010;21(3):833-42. doi: 10.3233/JAD-2010-091711.
7
Statistical power analyses using G*Power 3.1: tests for correlation and regression analyses.使用 G*Power 3.1 进行统计功效分析:相关和回归分析的检验。
Behav Res Methods. 2009 Nov;41(4):1149-60. doi: 10.3758/BRM.41.4.1149.
8
Expression of SORL1 and a novel SORL1 splice variant in normal and Alzheimers disease brain.SORL1 的表达及其在正常和阿尔茨海默病脑中的新型剪接变异体。
Mol Neurodegener. 2009 Nov 4;4:46. doi: 10.1186/1750-1326-4-46.
9
Implication of sex and SORL1 variants in italian patients with Alzheimer disease.性别及SORL1基因变异在意大利阿尔茨海默病患者中的意义
Arch Neurol. 2009 Oct;66(10):1260-6. doi: 10.1001/archneurol.2009.101.
10
Development of an immunoassay for the quantification of soluble LR11, a circulating marker of atherosclerosis.开发一种用于定量检测可溶性LR11的免疫测定法,可溶性LR11是动脉粥样硬化的一种循环标志物。
Clin Chem. 2009 Oct;55(10):1801-8. doi: 10.1373/clinchem.2009.127027. Epub 2009 Aug 6.